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EDITORIAL
Diabetes, a cause of progressive sarcopenia in dialysis patients?
Pupim et al [1] have identified diabetes as a risk factor for
loss of lean body mass in incident dialysis patients. Lean
body mass is composed of body cell mass and extracellu-
lar fluid. The most vulnerable compartment within body
cell mass is skeletal muscle. Changes in muscle mass are
accompanied by changes in physical function marked by
decreased strength and mobility. Because muscle mass
tends to decline continuously with increasing vintage
among dialysis patients, finding an approachable mecha-
nism to halt or slow the decline could have significant im-
pact on patient function. Because insulin resistance and
diabetes can be approached therapeutically, recognition
that diabetes imposes independent and significant risk to
tissue wasting presents opportunities both for interven-
tion and to probe mechanism. The magnitude of loss of
lean body mass, a mean of 3.4 kg/year, if continued lin-
early, would lead to substantial sarcopenia. Malnutrition,
defined by low serum albumin and prealbumin, are gener-
ally observed among diabetic dialysis patients. However,
the magnitude of loss of lean body mass observed here
is not reflected in cross-sectional measurements of urea
volume of distribution or anthopometric measures of lean
body mass by others [2, 3]. In the HEMO study, there was
no difference in urea volume of distribution at baseline
among a prevalent dialysis patient population [2]. While
this measure may not be quantitatively as precise as other
direct measures of lean body mass, the lack of difference
between nondiabetic and diabetic patients would suggest
that ongoing differences in loss of lean body mass such as
observed during the first year of treatment are unlikely
to continue in a linear fashion.
Chronic renal failure is accompanied both by alter-
ations in plasma protein composition and by loss of lean
body mass, which may be an outcome either of inadequate
nutritional intake or inflammation or a combination of
both processes. In longitudinal studies, a decline in phase
angle measured by bioimpedance is associated with both
nutritional factors, and inflammation [4], as are changes
in creatinine, a reporter of muscle mass [5]. Experimen-
tal models of diabetes in the rat are indeed associated
with decreased muscle protein synthesis and increased
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catabolism [6], suggesting that diabetes either by these
or other mechanisms may affect muscle mass. Truncal
obesity, a component of the metabolic syndrome, is asso-
ciated with increased TNFa and IL-6 levels in type 2 di-
abetics without renal failure and is associated with lower
body cell mass [7], providing a potential mechanistic link.
Activity of NFjB by the inflammatory cascade leads to
muscle protein catabolism [8] and impairs repair mecha-
nisms [9], leading to loss of muscle mass. While diabetic
patients in the current study indeed had a greater fat mass,
the authors found no association between a single cross-
sectional measurement of CRP and subsequent changes
in lean body mass. If this is the metabolic pathway link-
ing diabetes to accelerated loss of lean body mass, the
mechanism would require uncoupling between a random
measure of CRP and the plasma levels of these cytokines.
Alternatively, a single measurement of cytokine activa-
tion may be inadequate in this patient population because
of the great variability in inflammation. This incident dial-
ysis cohort of diabetic patients also had significantly more
urinary protein loss than the nondiabetic subjects. In-
deed, urinary protein was well within the nephrotic range.
This also presents a potential confounding variable be-
cause liver protein synthesis increases in response to uri-
nary protein loss with no change in over all body amino
acid economy [10]. The amino acids in proteins lost in
the urine, mostly generated in the liver, clearly must be
replaced by amino acids coming from other tissue stores.
The most likely candidate is muscle. While the diabetic
patients may have come to dialysis with greater expan-
sion of extracellular fluid than the nondiabetic patients,
the authors established that muscle mass, as estimated by
creatinine generation, was not significantly different be-
tween diabetic and nondiabetic patients, making such a
confounding effect unlikely. Gastroparesis or other fac-
tors associated with diabetes may also have contributed to
the disproportionate loss of lean body mass in the diabet-
ics; however, the loss of lean body mass was not accom-
panied by a decrease in fat mass as well. Indeed, body
composition changed to that of increasing adiposity in
the dialysis patients. Recognizing that diabetes may be
an independent variable associated with the rather pro-
found loss of lean body mass opens the question of mech-
anism, and potentially provides an option of intervention
with PPARc agonists to directly approach mechanisms
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of insulin resistance in this especially vulnerable cohort
within this already high-risk pool of patients.
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